A Study in Men With Benign Prostatic Hyperplasia

NCT01097707 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

414

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to insufficient efficacy

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG: LY500307
DRUG: Placebo

Sponsor

Eli Lilly and Company